Participant flow20

How many started, completed or left each group, period by period.

1 to 20 of 20

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	763
Overall Study	STARTED	Nevirapine	759
Overall Study	Week 8 Visit	Placebo	759
Overall Study	Week 8 Visit	Nevirapine	759
Overall Study	Month 3 Visit	Placebo	759
Overall Study	Month 3 Visit	Nevirapine	755
Overall Study	Month 4 Visit	Placebo	758
Overall Study	Month 4 Visit	Nevirapine	752
Overall Study	Month 5 Visit	Placebo	756
Overall Study	Month 5 Visit	Nevirapine	750
Overall Study	Month 6 Visit	Placebo	748
Overall Study	Month 6 Visit	Nevirapine	748
Overall Study	Month 9 Visit	Placebo	741
Overall Study	Month 9 Visit	Nevirapine	741
Overall Study	Month 12 Visit	Placebo	733
Overall Study	Month 12 Visit	Nevirapine	735
Overall Study	COMPLETED	Placebo	681
Overall Study	COMPLETED	Nevirapine	675
Overall Study	NOT COMPLETED	Placebo	82
Overall Study	NOT COMPLETED	Nevirapine	84

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00074412/flow